发布求助
文献互助 智能选刊 最新文献

Annals of Oncology最新文献

筛选
英文 中文
14P EED inhibition renders vulnerability to immunotherapy by rewiring ceramide metabolism in pancreatic cancer
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.023
{"title":"14P EED inhibition renders vulnerability to immunotherapy by rewiring ceramide metabolism in pancreatic cancer","authors":"","doi":"10.1016/j.annonc.2024.08.023","DOIUrl":"10.1016/j.annonc.2024.08.023","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015424/pdfft?md5=def166003201b26c218623a821badc5f&pid=1-s2.0-S0923753424015424-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
85P True single-circulating tumor cell genomics reveals enriched therapy-resistance signatures in advanced colorectal cancer patients
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.093
{"title":"85P True single-circulating tumor cell genomics reveals enriched therapy-resistance signatures in advanced colorectal cancer patients","authors":"","doi":"10.1016/j.annonc.2024.08.093","DOIUrl":"10.1016/j.annonc.2024.08.093","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016120/pdfft?md5=72907e6dc921a0beb6361776f84b53cd&pid=1-s2.0-S0923753424016120-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
86P Making the precision oncology landscape of Europe and the Republic of Ireland programmatically accessible
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.094
{"title":"86P Making the precision oncology landscape of Europe and the Republic of Ireland programmatically accessible","authors":"","doi":"10.1016/j.annonc.2024.08.094","DOIUrl":"10.1016/j.annonc.2024.08.094","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016132/pdfft?md5=ae5749db34840c24243d04e659c9e76c&pid=1-s2.0-S0923753424016132-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
80P Development of a next-generation sequencing diagnostics recommender tool in the framework of the molecular tumor board Freiburg
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.088
{"title":"80P Development of a next-generation sequencing diagnostics recommender tool in the framework of the molecular tumor board Freiburg","authors":"","doi":"10.1016/j.annonc.2024.08.088","DOIUrl":"10.1016/j.annonc.2024.08.088","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016077/pdfft?md5=88111f6cff53c354f2b0e15c157321c6&pid=1-s2.0-S0923753424016077-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142244024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
84P Advancing precision oncology: Integrating immune landscape and genomics for tailored therapy in metastatic cancer patients
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.092
{"title":"84P Advancing precision oncology: Integrating immune landscape and genomics for tailored therapy in metastatic cancer patients","authors":"","doi":"10.1016/j.annonc.2024.08.092","DOIUrl":"10.1016/j.annonc.2024.08.092","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016119/pdfft?md5=98bff3ec4a4b67dbcc503ee0410a1dd7&pid=1-s2.0-S0923753424016119-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
34P A novel gene family underlying cancer cell resilience
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.043
{"title":"34P A novel gene family underlying cancer cell resilience","authors":"","doi":"10.1016/j.annonc.2024.08.043","DOIUrl":"10.1016/j.annonc.2024.08.043","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092375342401562X/pdfft?md5=7d969d899473ac960a8d09d079a6b053&pid=1-s2.0-S092375342401562X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41P Cancer therapy-related cardiac dysfunction (CTRCD) after radiation therapy for breast cancer: Results of the French BACCARAT study
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.050
{"title":"41P Cancer therapy-related cardiac dysfunction (CTRCD) after radiation therapy for breast cancer: Results of the French BACCARAT study","authors":"","doi":"10.1016/j.annonc.2024.08.050","DOIUrl":"10.1016/j.annonc.2024.08.050","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015692/pdfft?md5=2f2563d2568f47696a2ea78142e48bb4&pid=1-s2.0-S0923753424015692-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
74MO Impact of MTAP loss on prognosis and efficacy of immune check point inhibitors across advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-1
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.082
{"title":"74MO Impact of MTAP loss on prognosis and efficacy of immune check point inhibitors across advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-1","authors":"","doi":"10.1016/j.annonc.2024.08.082","DOIUrl":"10.1016/j.annonc.2024.08.082","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016016/pdfft?md5=4881e1205f14f038021eb53b6be6be3b&pid=1-s2.0-S0923753424016016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
About the European Society for Medical Oncology (ESMO)
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/S0923-7534(24)03810-9
{"title":"About the European Society for Medical Oncology (ESMO)","authors":"","doi":"10.1016/S0923-7534(24)03810-9","DOIUrl":"10.1016/S0923-7534(24)03810-9","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424038109/pdfft?md5=0a636ef8045f8fa5a60e25939ced0f22&pid=1-s2.0-S0923753424038109-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
30P CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.039
{"title":"30P CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors","authors":"","doi":"10.1016/j.annonc.2024.08.039","DOIUrl":"10.1016/j.annonc.2024.08.039","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015588/pdfft?md5=3858aed639354d87f75d99a67a61dde7&pid=1-s2.0-S0923753424015588-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信